These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2009347)

  • 1. Palmitic acid as an excipient in implants for sustained release of insulin.
    Wang PY
    Biomaterials; 1991 Jan; 12(1):57-62. PubMed ID: 2009347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged release of insulin by cholesterol-matrix implant.
    Wang PY
    Diabetes; 1987 Sep; 36(9):1068-72. PubMed ID: 3301475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reliability of a compressed mixture of insulin and palmitic acid to sustain a reduction in hyperglycemia in rodents.
    Wang PY
    ASAIO Trans; 1987; 33(3):319-22. PubMed ID: 3314925
    [No Abstract]   [Full Text] [Related]  

  • 4. Compressed poly(vinyl alcohol)-polycaprolactone admixture as a model to evaluate erodible implants for sustained drug delivery.
    Wang PY
    J Biomed Mater Res; 1989 Jan; 23(1):91-104. PubMed ID: 2651448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow release of insulin from a biodegradable matrix implanted in diabetic rats.
    Goosen MF; Leung YF; O'Shea GM; Chou S; Sun AM
    Diabetes; 1983 May; 32(5):478-81. PubMed ID: 6341132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External control of drug release: controlled release of insulin from a hydrophilic polymer implant by ultrasound irradiation in diabetic rats.
    Miyazaki S; Yokouchi C; Takada M
    J Pharm Pharmacol; 1988 Oct; 40(10):716-7. PubMed ID: 2907539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of hyperglycaemia in diabetic rabbits by a combination of implants.
    Wang PY
    J Biomed Eng; 1993 Mar; 15(2):106-12. PubMed ID: 8459687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplemental insulin delivery from an implanted reservoir activated by external compression.
    Wang PY; Lee MC; Shelton DM; Boone DL; Kothe E
    ASAIO Trans; 1988; 34(3):270-3. PubMed ID: 3196519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetically enhanced insulin release in diabetic rats.
    Kost J; Wolfrum J; Langer R
    J Biomed Mater Res; 1987 Dec; 21(12):1367-73. PubMed ID: 3323204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One month of sustained release of insulin from a polymer implant.
    Creque HM; Langer R; Folkman J
    Diabetes; 1980 Jan; 29(1):37-40. PubMed ID: 6991315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release of insulin by double-layered implant using poly(D,L-lactic acid).
    Yamakawa I; Kawahara M; Watanabe S; Miyake Y
    J Pharm Sci; 1990 Jun; 79(6):505-9. PubMed ID: 2203895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-albumin microbeads: an implantable, biodegradable system.
    Goosen MF; Leung YF; Chou S; Sun AM
    Biomater Med Devices Artif Organs; 1982; 10(3):205-18. PubMed ID: 6760912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood glucose profiles in diabetic rodents using different insulin preparations.
    Schneider S; Weber R; Luippold G
    Arzneimittelforschung; 2004; 54(12):842-6. PubMed ID: 15646368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of blood glucose by sustained delivery of insulin via ALCAP ceramics in rats.
    Muzina DJ; Snow KR; Bajpai PK
    Biomed Sci Instrum; 1989; 25():191-202. PubMed ID: 2663097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfabricated microporous membranes reduce the host immune response and prolong the functional lifetime of a closed-loop insulin delivery implant in a type 1 diabetic rat model.
    Li J; Chu MK; Gordijo CR; Abbasi AZ; Chen K; Adissu HA; Löhn M; Giacca A; Plettenburg O; Wu XY
    Biomaterials; 2015 Apr; 47():51-61. PubMed ID: 25682160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subconjunctivally Implanted Hydrogels for Sustained Insulin Release to Reduce Retinal Cell Apoptosis in Diabetic Rats.
    Imai H; Misra GP; Wu L; Janagam DR; Gardner TW; Lowe TL
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7839-46. PubMed ID: 26658505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of sustained release of recombinant rat insulin-like growth factor-1 from poly (lactide-CO-glycolide ) microspheres on bone formation in the peri-implant areas in Goto-Kakizaki rats with type 2 diabetes].
    Yu M; Hui XM; Wang F; Zhang N; Zhang HP; Song YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Jun; 32(3):260-4. PubMed ID: 20602874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats.
    Salvioni L; Fiandra L; Del Curto MD; Mazzucchelli S; Allevi R; Truffi M; Sorrentino L; Santini B; Cerea M; Palugan L; Corsi F; Colombo M
    Pharmacol Res; 2016 Aug; 110():122-130. PubMed ID: 27181095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release of insulin from a hydrophilic polymer matrix implanted in diabetic rats.
    Miyazaki S; Yokouchi C; Takada M
    Chem Pharm Bull (Tokyo); 1988 Sep; 36(9):3689-91. PubMed ID: 3071428
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels.
    Liu J; Zhang SM; Chen PP; Cheng L; Zhou W; Tang WX; Chen ZW; Ke CM
    J Mater Sci Mater Med; 2007 Nov; 18(11):2205-10. PubMed ID: 17668296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.